Albertsons (ACI) Q2 2025 earnings review
Digital & Pharmacy Drive Sales, but Squeeze Margins; ACI Doubles Down with $750M Buyback
Albertsons reported a familiar story in Q2: solid top-line growth driven by strategic priorities, but persistent pressure on profitability. Identical sales grew 2.2%, powered by strong momentum in digital (+23%) and pharmacy (+19%) sales. However, this growth came at a cost, as a mix shift to these lower-margin channels contributed to a 6% YoY decline in Adjusted EBITDA. Adjusted EPS fell to $0.44 from $0.51 a year ago. In a significant vote of confidence, management announced a new $750 million accelerated share repurchase (ASR), which prompted an increase in the full-year EPS guidance, even as the core operational profit outlook remained unchanged.
🐂 Bull Case
The company continues to execute on its strategic pillars. Digital sales grew 23% and the loyalty program expanded 13% to 48.7 million members, creating a powerful customer engagement flywheel.
The new $750M ASR and an increased repurchase authorization signal strong management conviction that the stock is undervalued and reflects confidence in future cash flow generation.
The company's productivity program is delivering tangible results, helping to lower the SG&A expense rate by 50 basis points (ex-fuel) and funding necessary investments in price and technology.
🐻 Bear Case
The strategic focus on digital and pharmacy, while driving sales, is structurally dilutive to margins. The gross margin rate (ex-fuel) fell 63 basis points, and Adjusted EBITDA margin remains stuck at 4.5%, down from 4.9% a year ago.
Despite top-line growth, underlying profitability is shrinking. Adjusted EBITDA and Adjusted EPS were both down year-over-year, indicating the company is not yet effectively translating its sales growth into bottom-line improvement.
⚖️ Verdict: ⚪
Mixed. Albertsons is successfully executing its strategy to grow high-engagement channels, but this is creating a significant and persistent drag on profitability. The large share buyback is a strong positive signal, but the core issue remains: balancing growth with margins. The success of the $1.5 billion productivity plan is critical to funding this transition and proving the long-term viability of the current model.
Key Themes
Margin Erosion from Strategic Mix Shift
The core challenge for Albertsons remains the margin dilution from its fastest-growing segments. The gross margin rate (ex-fuel/LIFO) declined 63 basis points YoY, a trend that has persisted for several quarters (-85 bps in Q1, -45 bps in Q4). Management accepts this as a trade-off for acquiring high-value digital and pharmacy customers but has yet to demonstrate a clear path to offsetting this structural pressure, which remains the primary drag on overall profitability.
Digital & Pharmacy Continue to Power Growth
The company's primary growth engines continue to perform consistently. Digital sales grew 23% YoY, in line with its three-year CAGR, and pharmacy sales grew a strong 19%. The pharmacy business is benefiting from share gains from competitor store closures, bringing in valuable customers who tend to have higher visit frequency and larger baskets. These two segments are the main drivers behind the company's stable identical sales growth.
Accelerating Technology and AI Adoption
Management provided new details on its technology modernization. The company is actively deploying AI agents across the business, highlighted by a new 'Ask AI' conversational search feature in its app to help customers build baskets. A partnership with OpenAI is being used to develop merchandising intelligence tools. This 'technology-first' approach is aimed at improving efficiency, personalization, and speed to market.
The 'Solid Results' Narrative Masks Profit Decline
Management's characterization of the quarter as 'solid' focuses on top-line execution but downplays weakening profitability. While identical sales were positive, Adjusted EBITDA declined 6% YoY to $848M and Adjusted EPS fell 14% to $0.44. This contradicts the positive narrative, as the current growth is not translating to the bottom line, a key concern for investors.
Productivity Program Funds Investments
The company's goal to achieve $1.5 billion in savings by fiscal 2027 is showing clear results on the SG&A line. Selling and administrative expenses as a percentage of sales (ex-fuel) improved by 50 basis points. Management stated these savings helped fund the 'surgical' price investments made during the quarter, demonstrating the program is working as the necessary fuel for the company's broader strategy.
Macro: Cautious Consumer Reinforces Value Strategy
The consumer remains focused on value, exhibiting behaviors like trading down to smaller package sizes, shifting to own brands, and using more coupons. This backdrop validates Albertsons' strategy of making surgical price investments and promoting its loyalty program's cash-off rewards. However, it also underscores the intensely competitive environment and the need for continued investment to maintain market share.
Other KPIs
The company announced a $750M accelerated share repurchase and increased its total authorization to $2.75B. Combined with the $550M repurchased year-to-date, this represents a significant acceleration in capital returns and a strong signal of management's belief that the stock is undervalued.
The loyalty program continues its steady growth, increasing 13% YoY. This program is a cornerstone of the company's strategy, providing rich data for personalization and the Albertsons Media Collective, and driving deeper engagement with the most valuable customers.
Guidance
Stable. The low end of the range was raised from 2.0%. The midpoint of 2.475% implies a consistent performance in the second half of the year compared to the 2.5% growth seen in the first half.
Decelerating. The guidance was left unchanged. With $1.96B delivered in H1, the midpoint of $3.85B implies approximately $1.89B in H2. This would represent a ~1.5% decline from the $1.92B in Adjusted EBITDA generated in the second half of FY24.
Stable. The range was raised from $2.03-$2.16. Management was clear that this increase is a direct result of the expected accretion from the $750M ASR and does not reflect an improvement in the underlying operational earnings outlook.